Amgen Warns Against Conflating Oncology And Inflammation Biosimilars

As Biosimilar Sales Track To $2bn

 
• By Dean Rudge
Red Umbrella Among Black Umbrellas
Amgen has underlined the distinction between oncology and inflammation. • Source: Shutterstock

More from Biosimilars

More from Products